By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Pfizer Joins Microbiome Movement with Second Genome
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Pfizer Joins Microbiome Movement with Second Genome
BusinessMedical Innovations

Pfizer Joins Microbiome Movement with Second Genome

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

gut bacteria prebioticsFirst published on MedCityNews.com. Scientific understanding of the microbiome – the ecosystem of bacteria in the gut – has matured to the point where the pharmaceutical industry recognizes it as a critical part of drug discovery, says Peter DiLaura, CEO of Second Genome.

gut bacteria prebioticsFirst published on MedCityNews.com. Scientific understanding of the microbiome – the ecosystem of bacteria in the gut – has matured to the point where the pharmaceutical industry recognizes it as a critical part of drug discovery, says Peter DiLaura, CEO of Second Genome.

“The microbiome certainly is not total picture of disease, but there’s now recognition that you can’t ignore it if you’re trying to understand complex chronic diseases,” he said.

Second Genome has just struck its second Big Pharma deal to explore the role of microbes in disease, and to identify potential new drug targets. Last summer, it paired up with Janssen Biotech to study ulcerative colitis. Now it’s working with Pfizer on what DiLaura called the largest microbiome study in humans to date.

More Read

The Latest on Burnout in Healthcare: What You Can Do
Can a $3 Million Prize Solve a $2.5 Billion Dollar Problem?
Medical Practice Branding and Website Imagery
Social Security Expands Online Services
Collaborating for Population Health Management Strategy

In an effort to better understand the relationship between the microbiome, obesity and metabolic disorders, they’ll study about 900 obese individuals selected by a team at Massachussets General Hospital over 12 months. In addition to looking at their microbiomes, they’ll also look at their genome and other components of the host biology to understand how interactions between the gut microbes of obese and non-obese people differ.

A correlation between microbes and metabolic disease has emerged in several recent studies, including studies of microbiome transplants in mice. Now that the correlation has been established, DiLaura said, it’s time to untangle the functional relationships that microbes have with the host, to determine how they could best be modulated to prevent or correct a diseased state.

For Pfizer, that knowledge could lead to better drugs for obesity and diabetes.

“Understanding the complex set of interactions between the gut microbes in obese and non-obese individuals is critical to our research in metabolic disease, a key area of focus at Pfizer,” said Barbara Sosnowski, vice President of external R&D innovation at Pfizer, in a statement.

The terms of the deal were not disclosed.

San Bruno, California-based Second Genome has raised more than $11 million in funding since its inception in 2009.

TAGGED:obesityPfizerpharmaSecond Genome
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025
contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025

You Might also Like

Artificial IntelligenceHealth careMedical Innovations

Benefits Of The Internet Of Things For Hospitals And Healthcare

April 24, 2019
affordable healthcare
BusinessHealth ReformPolicy & Law

How High-Deductible Insurance Fuels Momentous Healthcare Shifts

July 2, 2015

Economist Highlights the Home Birth Debate

April 4, 2011
BusinessNews

CMS Announces Re-Examination of Timeline for ICD-10 – Is the Pressure Off?

February 17, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?